Evidence status: CURRENT AUTHORITY AND OPEN PARTICIPATION RECORD. The Michigan Department of Health and Human Services is the ultimate state authority over the Medicaid Health Plan Common Formulary coverage policy. The current high-MME Pain Medication Agreement condition therefore has an administrative policy-change route.

Current responsible leadership

Meghan Groen is Chief Deputy Director for Health Services at MDHHS and serves as Michigan’s State Medicaid Director. Health Services oversees the state Medicaid program.

Common Formulary authority

Michigan’s Common Formulary workgroup includes Medicaid health plan representatives and makes recommendations, but MDHHS retains ultimate authority over Common Formulary coverage parameters.

Current public participation window

MDHHS has announced its annual Michigan Medicaid Health Plan Common Formulary stakeholder meeting for October 27, 2026. The department stated that people unable to attend may submit questions or comments to the Common Formulary mailbox by October 21, 2026. The annual meeting supplements the quarterly written public-comment periods.

Focused Michigan Medicaid reform question

The precise Contract-for-Care question is whether the signed Pain Medication Agreement should remain a condition inside the high-MME coverage record when individualized clinical justification, MAPS review, toxicology, medication reconciliation, non-opioid treatment review, risk assessment, and other safety documentation are already required.

Current authority sources

Reviewed: October 5, 2026.

Freshness note: Named officeholders, committee assignments, meeting dates, and public-comment windows are time-sensitive. The responsible institution and legal change route are the durable authority. Recheck the linked official source before outreach.